News

Effective January 1^st, 2024, CCRA welcomes Dr. Rosilene Kraft as the incoming patient/family representative on the CCRA Advisory Board. Most recently, Rosilene served on the 2023 PIP Working Committee and was cross-appointed to the conference Scientific Program Committee. Sh... Read More »

Effective October 9, 2024, the CCRA Advisory Board voted to modify the Exceptional Leadership in Cancer Research to the “Philip E. Branton Award for Exceptional Leadership in Cancer Research” to acknowledge and recognize Dr. Branton’s pivotal role in the creation of CCRA and his extraordinary contribution to Canada’s cancer research community. Dr. Branton was the inaugural recipient of this award when the program was initiated in 2011. Dr. Branton obtained his PhD from the Ontario Cancer I... Read More »